BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26074416)

  • 1. Analysis of IL10 haplotypes in primary Sjögren's syndrome patients from Western Mexico: Relationship with mRNA expression, IL-10 soluble levels, and autoantibodies.
    Vázquez-Villamar M; Palafox-Sánchez CA; Muñoz-Valle JF; Valle Y; Orozco-Barocio G; Hernández-Bello J; Oregon-Romero E
    Hum Immunol; 2015 Jul; 76(7):473-9. PubMed ID: 26074416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of interleukin-10 in rheumatoid arthritis: Relationship with IL10 haplotypes and autoantibodies.
    Hernández-Bello J; Oregón-Romero E; Vázquez-Villamar M; García-Arellano S; Valle Y; Padilla-Gutiérrez JR; Román-Fernández IV; Palafox-Sánchez CA; Martínez-Bonilla GE; Muñoz-Valle JF
    Cytokine; 2017 Jul; 95():88-96. PubMed ID: 28254559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
    Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
    Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome.
    Font J; García-Carrasco M; Ramos-Casals M; Aldea AI; Cervera R; Ingelmo M; Vives J; Yagüe J
    Rheumatology (Oxford); 2002 Sep; 41(9):1025-30. PubMed ID: 12209037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M
    Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.
    Willeke P; Gaubitz M; Schotte H; Becker H; Domschke W; Schlüter B
    Scand J Rheumatol; 2008; 37(4):293-9. PubMed ID: 18612930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD28 and CTLA4 haplotypes with susceptibility to primary Sjögren's syndrome in Mexican population.
    López-Villalobos EF; Carrillo-Ballesteros FJ; Muñoz-Valle JF; Palafox-Sánchez CA; Valle Y; Orozco-Barocio G; Oregon-Romero E
    J Clin Lab Anal; 2019 Jan; 33(1):e22620. PubMed ID: 29992636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
    Anaya JM; Correa PA; Herrera M; Eskdale J; Gallagher G
    J Rheumatol; 2002 Sep; 29(9):1874-6. PubMed ID: 12233881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.
    Palafox-Sánchez CA; Oregon-Romero E; Salazar-Camarena DC; Valle YM; Machado-Contreras JR; Cruz A; Orozco-López M; Orozco-Barocio G; Vázquez-Del Mercado M; Muñoz-Valle JF
    Clin Exp Med; 2015 Nov; 15(4):439-46. PubMed ID: 25253090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
    Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
    Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome.
    Fox RI; Kang HI; Ando D; Abrams J; Pisa E
    J Immunol; 1994 Jun; 152(11):5532-9. PubMed ID: 8189070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenetics of primary Sjögren's syndrome in Colombians.
    Anaya JM; Mantilla RD; Correa PA
    Semin Arthritis Rheum; 2005 Apr; 34(5):735-43. PubMed ID: 15846589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
    Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
    Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome?
    Sellam J; Miceli-Richard C; Gottenberg JE; Proust A; Ittah M; Lavie F; Loiseau P; Mariette X
    Rheumatology (Oxford); 2008 Apr; 47(4):437-41. PubMed ID: 18296721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
    de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
    J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
    Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
    Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.